Terug
Dagbereik
€ 4,52
€ 4,75
52-Weeksbereik
€ 2,37
€ 6,18
Volume
726.609
50D / 200D Gem.
€ 4,71
/
€ 4,27
Vorige Slotkoers
€ 4,48
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,1 | 0,4 |
| P/B | 1,8 | 2,9 |
| ROE % | -18,1 | 3,7 |
| Net Margin % | -33,0 | 3,9 |
| Rev Growth 5Y % | 12,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 6,00
+27.4%
Forward WPA
-€ 0,21
Omzet Sch.
210 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
-€ 0,08
-€ 0,08 – -€ 0,08
|
260 M | 1 |
| FY2028 |
-€ 0,05
-€ 0,05 – -€ 0,05
|
250 M | 2 |
| FY2027 |
-€ 0,14
-€ 0,17 – -€ 0,09
|
220 M | 2 |
Belangrijkste Punten
Revenue grew 12,02% annually over 5 years — strong growth
Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -8,77M
Revenue growth is decelerating — 1Y growth trails 5Y average by 11,50%
Capital efficient — spends only 2,03% of revenue on capex
Groei
Revenue Growth (5Y)
12,02%
Revenue (1Y)0,52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-18,05%
ROIC-8,08%
Net Margin-33,02%
Op. Margin-20,04%
Veiligheid
Debt / Equity
0,10
Current Ratio5,04
Interest Coverage-85,20
Waardering
P/E Ratio
-9,10
P/B Ratio1,77
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,52% | Revenue Growth (3Y) | 2,17% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,02% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 201,49M | Net Income (TTM) | -66,54M |
| ROE | -18,05% | ROA | -14,42% |
| Gross Margin | 51,84% | Operating Margin | -20,04% |
| Net Margin | -33,02% | Free Cash Flow (TTM) | -8,77M |
| ROIC | -8,08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 5,04 |
| Interest Coverage | -85,20 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,10 | P/B Ratio | 1,77 |
| P/S Ratio | 3,00 | PEG Ratio | -0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 605,47M | Enterprise Value | 547,64M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 201,49M | 200,45M | 193,02M | 164,04M | 127,95M |
| Net Income | -66,54M | -6,02M | -12,15M | 2,58M | 3,00M |
| EPS (Diluted) | -0,52 | -0,05 | -0,09 | 0,02 | 0,03 |
| Gross Profit | 104,46M | 111,11M | 109,43M | 100,97M | 79,14M |
| Operating Income | -40,38M | -20,52M | -27,85M | -1,80M | 9,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 461,54M | 499,50M | 494,46M | 519,48M | 463,31M |
| Total Liabilities | 119,80M | 103,76M | 101,39M | 93,93M | 57,92M |
| Shareholders' Equity | 341,74M | 395,74M | 393,06M | 425,30M | 405,04M |
| Total Debt | 33,02M | 17,02M | 14,14M | 18,09M | 0,0 |
| Cash & Equivalents | 90,85M | 98,72M | 167,30M | 296,60M | 364,62M |
| Current Assets | 392,00M | 396,45M | 392,06M | 454,02M | 431,73M |
| Current Liabilities | 77,80M | 67,66M | 56,23M | 49,04M | 33,18M |